353 related articles for article (PubMed ID: 35814833)
21. Lipid metabolism in cancer progression and therapeutic strategies.
Fu Y; Zou T; Shen X; Nelson PJ; Li J; Wu C; Yang J; Zheng Y; Bruns C; Zhao Y; Qin L; Dong Q
MedComm (2020); 2021 Mar; 2(1):27-59. PubMed ID: 34766135
[TBL] [Abstract][Full Text] [Related]
22. Metabolic Reprogramming in the Tumor Microenvironment With Immunocytes and Immune Checkpoints.
Xu Y; He L; Fu Q; Hu J
Front Oncol; 2021; 11():759015. PubMed ID: 34858835
[TBL] [Abstract][Full Text] [Related]
23. O-GlcNAcylation Enhances Double-Strand Break Repair, Promotes Cancer Cell Proliferation, and Prevents Therapy-Induced Senescence in Irradiated Tumors.
Efimova EV; Appelbe OK; Ricco N; Lee SS; Liu Y; Wolfgeher DJ; Collins TN; Flor AC; Ramamurthy A; Warrington S; Bindokas VP; Kron SJ
Mol Cancer Res; 2019 Jun; 17(6):1338-1350. PubMed ID: 30885991
[TBL] [Abstract][Full Text] [Related]
24. Metabolic Reprogramming of Chemoresistant Cancer Cells and the Potential Significance of Metabolic Regulation in the Reversal of Cancer Chemoresistance.
Chen X; Chen S; Yu D
Metabolites; 2020 Jul; 10(7):. PubMed ID: 32708822
[TBL] [Abstract][Full Text] [Related]
25. Regulation of Metabolic Reprogramming by Long Non-Coding RNAs in Cancer.
Sellitto A; Pecoraro G; Giurato G; Nassa G; Rizzo F; Saggese P; Martinez CA; Scafoglio C; Tarallo R
Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298698
[TBL] [Abstract][Full Text] [Related]
26. Nano-medicine therapy reprogramming metabolic network of tumour microenvironment: new opportunity for cancer therapies.
Zhang X; An M; Zhang J; Zhao Y; Liu Y
J Drug Target; 2024 Dec; 32(3):241-257. PubMed ID: 38251656
[TBL] [Abstract][Full Text] [Related]
27. Role and therapeutic targeting of glutamine metabolism in non‑small cell lung cancer (Review).
Zhou L; Zhang Q; Zhu Q; Zhan Y; Li Y; Huang X
Oncol Lett; 2023 Apr; 25(4):159. PubMed ID: 36936031
[TBL] [Abstract][Full Text] [Related]
28. Metabolic Regulation of Epigenetic Modifications and Cell Differentiation in Cancer.
Saggese P; Sellitto A; Martinez CA; Giurato G; Nassa G; Rizzo F; Tarallo R; Scafoglio C
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33339101
[TBL] [Abstract][Full Text] [Related]
29. Role of HIF-1α/ERRα in Enhancing Cancer Cell Metabolism and Promoting Resistance of Endometrial Cancer Cells to Pyroptosis.
Su P; Yu L; Mao X; Sun P
Front Oncol; 2022; 12():881252. PubMed ID: 35800058
[TBL] [Abstract][Full Text] [Related]
30. The roles of glucose metabolic reprogramming in chemo- and radio-resistance.
Lin J; Xia L; Liang J; Han Y; Wang H; Oyang L; Tan S; Tian Y; Rao S; Chen X; Tang Y; Su M; Luo X; Wang Y; Wang H; Zhou Y; Liao Q
J Exp Clin Cancer Res; 2019 May; 38(1):218. PubMed ID: 31122265
[TBL] [Abstract][Full Text] [Related]
31. VDAC1 Silencing in Cancer Cells Leads to Metabolic Reprogramming That Modulates Tumor Microenvironment.
Zerbib E; Arif T; Shteinfer-Kuzmine A; Chalifa-Caspi V; Shoshan-Barmatz V
Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34200480
[TBL] [Abstract][Full Text] [Related]
32. The SIRT2/cMYC Pathway Inhibits Peroxidation-Related Apoptosis In Cholangiocarcinoma Through Metabolic Reprogramming.
Xu L; Wang L; Zhou L; Dorfman RG; Pan Y; Tang D; Wang Y; Yin Y; Jiang C; Zou X; Wu J; Zhang M
Neoplasia; 2019 May; 21(5):429-441. PubMed ID: 30933885
[TBL] [Abstract][Full Text] [Related]
33. [A Review of the Lipid Metabolism Reprogramming in Tumor Associated Macrophages].
Zhao K; Shi RC; Miao HM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Jan; 52(1):45-49. PubMed ID: 33474888
[TBL] [Abstract][Full Text] [Related]
34. Nano-realgar suppresses lung cancer stem cell growth by repressing metabolic reprogramming.
Yang FR; Zhao YF; Hu XW; Liu ZK; Yu XD; Li CY; Li XR; Li HJ
Gene; 2021 Jul; 788():145666. PubMed ID: 33887368
[TBL] [Abstract][Full Text] [Related]
35. Correlation of Glucose Metabolism with Cancer and Intervention with Traditional Chinese Medicine.
Lai GH; Wang F; Nie DR; Lei SJ; Wu ZJ; Cao JX; Tang LL
Evid Based Complement Alternat Med; 2022; 2022():2192654. PubMed ID: 36276846
[TBL] [Abstract][Full Text] [Related]
36. The Role of MicroRNAs in Lung Cancer Metabolism.
Azizi MIHN; Othman I; Naidu R
Cancers (Basel); 2021 Apr; 13(7):. PubMed ID: 33916349
[TBL] [Abstract][Full Text] [Related]
37. Loss of the tumor suppressor LKB1 promotes metabolic reprogramming of cancer cells via HIF-1α.
Faubert B; Vincent EE; Griss T; Samborska B; Izreig S; Svensson RU; Mamer OA; Avizonis D; Shackelford DB; Shaw RJ; Jones RG
Proc Natl Acad Sci U S A; 2014 Feb; 111(7):2554-9. PubMed ID: 24550282
[TBL] [Abstract][Full Text] [Related]
38. Metabolic Reprogramming in Cancer Cells: Emerging Molecular Mechanisms and Novel Therapeutic Approaches.
Navarro C; Ortega Á; Santeliz R; Garrido B; Chacín M; Galban N; Vera I; De Sanctis JB; Bermúdez V
Pharmaceutics; 2022 Jun; 14(6):. PubMed ID: 35745875
[TBL] [Abstract][Full Text] [Related]
39. LKB1 deficiency-induced metabolic reprogramming in tumorigenesis and non-neoplastic diseases.
Zhang Y; Meng Q; Sun Q; Xu ZX; Zhou H; Wang Y
Mol Metab; 2021 Feb; 44():101131. PubMed ID: 33278637
[TBL] [Abstract][Full Text] [Related]
40. Metabolic reprogramming of cancer-associated fibroblasts by TGF-β drives tumor growth: connecting TGF-β signaling with "Warburg-like" cancer metabolism and L-lactate production.
Guido C; Whitaker-Menezes D; Capparelli C; Balliet R; Lin Z; Pestell RG; Howell A; Aquila S; Andò S; Martinez-Outschoorn U; Sotgia F; Lisanti MP
Cell Cycle; 2012 Aug; 11(16):3019-35. PubMed ID: 22874531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
